Alternative Cancer Cures: “Unproven” or “Disproven”?

@article{Vickers2004AlternativeCC,
  title={Alternative Cancer Cures: “Unproven” or “Disproven”?},
  author={Andrew J. Vickers},
  journal={CA: A Cancer Journal for Clinicians},
  year={2004},
  volume={54}
}
  • A. Vickers
  • Published 1 March 2004
  • Medicine
  • CA: A Cancer Journal for Clinicians
Oncology has always coexisted with therapies offered outside of conventional cancer treatment centers and based on theories not found in biomedicine. These alternative cancer cures have often been described as “unproven,” suggesting that appropriate clinical trials have not been conducted and that the therapeutic value of the treatment is unknown. Contrary to much popular and scientific writing, many alternative cancer treatments have been investigated in good quality clinical trials, and they… Expand
Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
TLDR
Complementary therapies have an increasingly important role in the control of symptoms associated with cancer and cancer treatment and should be investigated for side effects and potential interactions with chemotherapy and other medications. Expand
Alternative Medicine in Children with Cancer – Facts and Myths
Complementary and alternative medicine (CAM) have become very popular nowadays among patients with can− cer. It has been estimated that about 42–73% of paediatric cancer patients had used at leastExpand
A Review: Comprehensive Study on Anticancer Therapy
Cancer known medically as a malignant neoplasm, is a broad group of diseases involving unregulated cell growth. Not all tumors are cancerous; benign tumors do not invade neighboring tissues and doExpand
Complementary and alternative (CAM) dietary therapies for cancer
TLDR
There is no evidence to support the claims that CAM dietary therapies cure cancer and the potential advantages and disadvantages of CAM diets are discussed. Expand
Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy.
TLDR
Overall prevalence of CTs among Italian cancer patients is high and is in accordance with the European average, in addition to clinical and sociodemographic factors, the resilience trait SOC also was associated with CT use. Expand
Prevention and treatment of cancer cachexia: new insights into an old problem.
TLDR
The present review will focus on the potential biochemical and molecular targets of CC therapy, and will define the rationale for a novel, gene therapy-based approach to treat cancer cachexia. Expand
The “therapeutic footprint” of medical, complementary and alternative therapies and a doctorˈs duty of care
TLDR
Understanding the difference between complementary and alternative therapies and how they differ from standard medical care helps doctors whose patients are using complementary or alternative therapies to define the boundaries between these therapies and professional medicine and provide appropriate disclosure of risks. Expand
Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study
TLDR
Breast cancer patients receiving prophylactic acupuncture during chemotherapy did not show better quality of life in the questionnaires in contrast to the reported positive effects in the qualitative interviews, but coping strategies for cancer appear to be important. Expand
Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer
TLDR
It was concluded that CINV and cancer pain are the only indications for acupuncture, acupressure or moxibustion currently supported by concrete evidence and future studies should be of high quality with a particular emphasis on designing adequate control interventions. Expand
A Systematic Review of Biosynthesized Metallic Nanoparticles as a Promising Anti-Cancer-Strategy
TLDR
This review gives an overview of the recent advancements in the biosynthesis of metallic nanoparticles and their possible anti-cancer activities, with particular emphasis on the mechanisms of action, and future research prospects of nano-therapeutics are also discussed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 59 REFERENCES
Alternative cancer cures
  • E. Ernst
  • Medicine
  • British Journal of Cancer
  • 2001
TLDR
This short article is aimed at enhancing oncologists’ understanding of complementary and alternative medicine (CAM), where a charismatic individual who claims to have found the answer to cancer gathers ardent supporters who lobby for a wider acceptance of this ACC. Expand
Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy
  • Medicine
  • BMJ
  • 1999
TLDR
Di Bella multitherapy did not show sufficient efficacy in patients with advanced cancer to warrant further clinical testing, and toxicity was evaluated using criteria developed by the World Health Organisation. Expand
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study.
TLDR
Investigation of the prevalent use of "alternative medicine", here called "non-proven therapies (NPT)", applied among Norwegian cancer patients found that healing by hand and faith healing were the preferred methods and herbs, vitamins, diets and Iscador were other popular methods. Expand
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
TLDR
Subcutaneous use of mistletoe lectin as adjuvant treatment after transurethral resection does not seem to affect the time to first recurrence, total number of recurrences or recurrence-free outcome. Expand
Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer.
TLDR
Under the specific conditions of this study, SC as a single agent was inactive in patients with advanced-stage cancer and had no salutary effect on quality of life. Expand
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels.
TLDR
The higher dose of Neovastat administered in this trial is associated with a survival benefit in RCC, which is not explained by differences in major prognostic factors. Expand
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy.
TLDR
The length of survival and quality of life in patients who received treatment at a prominent unorthodox cancer clinic in addition to conventional treatment and in matched control patients from an academic cancer center who received only conventional treatment were compared. Expand
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.
TLDR
Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment and patients exposed to this agent should be instructed about the danger of cyanide poisoning, and their blood cyanide levels should be carefully monitored. Expand
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
TLDR
This trial failed to demonstrate any benefit for patients who received hydrazine sulfate and no significant differences were noted in the two study arms with regard to toxicity or quality of life (QL). Expand
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
TLDR
This trial failed to demonstrate any benefit for hydrazine sulfate in cancer patients and showed trends both for poorer survival and for poorer quality of life (QL) in the Hydrazine group. Expand
...
1
2
3
4
5
...